Last update 08 May 2025

CCL19 x IL-7Rα x CD19

Basic Info

Related Targets
CCL19IL-7RαCD19

Related

1
Drugs associated with CCL19 x IL-7Rα x CD19
CD19 CAR-T Expressing IL7 and CCL19(First Affiliated Hospital of Zhejiang University)
Target
CCL19 x CD19 x IL-7Rα
Mechanism
CCL19 modulators [+2]
Active Org.-
Originator Org.
The First Affiliated Hospital, Zhejiang University Sch of MedThe First Affiliated Hospital, Zhejiang University Sch of Med
Active Indication
Large B-cell lymphoma
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with CCL19 x IL-7Rα x CD19
NCT03929107
/ Unknown statusPhase 2IIT
Interleukin-7 and Chemokine (C-C Motif) -Ligand 19-expressing CD19-CAR-T for Refractory/Relapsed B Cell Lymphoma
100 Clinical Results associated with CCL19 x IL-7Rα x CD19
Login to view more data
100 Translational Medicine associated with CCL19 x IL-7Rα x CD19
Login to view more data
0 Patents (Medical) associated with CCL19 x IL-7Rα x CD19
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free